Pneumonitis with Antiandrogens

  1. Charles L. Bennett, MD, PhD; and
  2. Oliver Sartor, MD
  1. From Veterans Affairs Chicago Healthcare System/Lakeside Division; Chicago, IL 60611; and Louisiana State University School of Medicine; New Orleans, LA 70112. Disclosure: Dr. Bennett has been a consultant to Cell Pathways, Schering-Plough, Inc., and AstraZeneca and has received grant support from the American Cancer Society related to nonsteroidal antiandrogens. Dr. Sartor has been a consultant for Sanofi-Synthelabo, Inc., Atrix Laboratories, Inc., and GTx, Inc., and has served on the monitoring board of Dendreon Corp.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be …

    « Previous | Next Article »Table of Contents